SGMO - Sangamo Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SGMO is currently covered by 10 analysts with an average price target of $6.76. This is a potential upside of $4.71 (229.76%) from yesterday's end of day stock price of $2.05.

Sangamo Therapeutics's activity chart (see below) currently has 36 price targets and 60 ratings on display. The stock rating distribution of SGMO is 79.41% BUY, 5.88% SELL and 14.71% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.77% with an average time for these price targets to be met of 209.31 days.

Highest price target for SGMO is $10, Lowest price target is $9, average price target is $6.76.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 14-Nov-2024. First documented stock forecast 09-Jan-2014.

Currently out of the existing stock ratings of SGMO, 27 are a BUY (79.41%), 2 are a SELL (5.88%), 5 are a HOLD (14.71%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$9

$6.95 (339.02%)

3 days ago
(14-Nov-2024)

3/5 (60%)

$6.85 (318.60%)

282

Buy

$10

$7.95 (387.80%)

$10

3 days ago
(14-Nov-2024)

0/11 (0%)

$7.85 (365.12%)

Hold

1 years 10 days ago
(07-Nov-2023)

0/1 (0%)

$12.85 (208.94%)

Hold

$1

$-1.05 (-51.22%)

$4

1 years 11 days ago
(06-Nov-2023)

2/3 (66.67%)

$0.56 (127.27%)

541

Hold

$2

$-0.05 (-2.44%)

1 years 14 days ago
(03-Nov-2023)

1/4 (25%)

$1.54 (334.78%)

360

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SGMO (Sangamo Therapeutics) average time for price targets to be met?

On average it took 209.31 days on average for the stock forecasts to be realized with a an average price target met ratio 45.77

Which analyst has the current highest performing score on SGMO (Sangamo Therapeutics) with a proven track record?

GENA WANG

Which analyst has the most public recommendations on SGMO (Sangamo Therapeutics)?

Gena Wang works at BARCLAYS and has 6 price targets and 3 ratings on SGMO

Which analyst is the currently most bullish on SGMO (Sangamo Therapeutics)?

Maury Raycroft with highest potential upside - $20.95

Which analyst is the currently most reserved on SGMO (Sangamo Therapeutics)?

Jim Birchenough with lowest potential downside - -$1.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?